NCT06187298View on ClinicalTrials.gov

Effect of Oral Combined Berberine and Curcumin Pharmacological Therapy on IBS

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

May 16, 2022

Study Completion Date

December 15, 2023

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

A combined supplement of Berberine and Curcumin (Enterophytol® PLUS) alongside standard of care

(Enterophytol® PLUS) alongside standard of care

Trial Locations (1)

Unknown

Liaquat University of Medical and Health Sciences, Jāmshoro

All Listed Sponsors
collaborator

University of Liege

OTHER

lead

Liaquat University of Medical & Health Sciences

OTHER

NCT06187298 - Effect of Oral Combined Berberine and Curcumin Pharmacological Therapy on IBS | Biotech Hunter | Biotech Hunter